New sulfurated derivatives of cinnamic acids and rosmaricine as inhibitors of STAT3 and NF-κB transcription factors

References

• Mantovani A. Molecular pathways linking inflammation and cancer. Curr Mol Med 2010;10:369–73.
   PubMed Web of Science ®Google Scholar
• Kannaiyan R, Hay HS, Rajendran P, et al. Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells. Br J Pharmacol 2011;164:1506–21.
   PubMed Web of Science ®Google Scholar
• Bromberg J, Darnell JE. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 2000;19:2468–73.
   PubMed Web of Science ®Google Scholar
• Deng J, Grande F, Neamati N. Small molecule inhibitors of Stat3 signaling pathway. Curr Cancer Drug Targets 2007;7:91–107.
   PubMed Web of Science ®Google Scholar
• Iwamaru S, Szymanski E, Iwado H, et al. A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo. Oncogene 2007;26:2435–44.
   PubMed Web of Science ®Google Scholar
• Siddiquee K, Zhang S, Guida WC, et al. Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity. Proc Natl Acad Sci USA 2007;104:7391–6.
   PubMed Web of Science ®Google Scholar
• Siveen KS, Sikka S, Surana R, et al. Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors. Biochim Biophys Acta 2014;1845:136–54.
   PubMed Web of Science ®Google Scholar
• Lee H, Herrmann A, Deng JH, et al. Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors. Cancer Cell 2009;15:283–93.
   PubMed Web of Science ®Google Scholar
• Rayet B, Gelinas C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene 1999;18:6938–47.
   PubMed Web of Science ®Google Scholar
• Karin M, Cao Y, Greten FR, et al. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002;2:301–10.
   PubMed Web of Science ®Google Scholar
• Aggarwal BB. Nuclear factor-kappaB: the enemy within. Cancer Cell 2004;6:203–8.
   PubMed Web of Science ®Google Scholar
• Chen F, Castranova V, Shi X. New insights into the role of nuclear factor-kappaB in cell growth regulation. Am J Pathol 2001;159:387–97.
   PubMed Web of Science ®Google Scholar
• Luo JL, Kamata H, Karin MJ. IKK/NF-kappaB signaling: balancing life and death – a new approach to cancer therapy. Clin Invest 2005;115:2625–32.
   Google Scholar
• Xiong A, Yang Z, Shen Y, et al. Transcription factor STAT3 as a novel molecular target for cancer prevention. Cancer 2014;6:926–57.
   Web of Science ®Google Scholar
• Debnath B, Xu S, Neamati N. Small molecule inhibitors of signal transducer and activator of transcription 3 (Stat3) protein. J Med Chem 2012;55:6645–83.
   PubMed Web of Science ®Google Scholar
• Trécul A, Morceau F, Dicato M, et al. Dietary compounds as potent inhibitors of the signal transducers and activators of transcription (STAT) 3 regulatory network. Genes Nutr 2012;111–25.
   PubMed Web of Science ®Google Scholar
• Lai PS, Rosa DA, Magdy Ali A, et al. A STAT inhibitor patent review: progress since 2011. Expert Opin Ther Pat 2015;25:1397–421.
   PubMed Web of Science ®Google Scholar
• Miklossy G, Hilliard TS, Turkson J. Therapeutic modulators of STAT signalling for human diseases. Nat Rev Drug Discov 2013;12:611–29.
   PubMed Web of Science ®Google Scholar
• Kim BH, Yi EH, Ye SK. Signal transducer and activator of transcription 3 as a therapeutic target for cancer and the tumor microenvironment. Arch Pharm Res 2016; 39:1085–99.
   PubMed Web of Science ®Google Scholar
• Furtek SL, Backos DS, Matheson CJ, et al. Strategies and approaches of targeting STAT3 for cancer treatment. ACS Chem Biol 2016;11:308–18.
   PubMed Web of Science ®Google Scholar
• Han X, Shen T, Lou H. Dietary polyphenols and their biological significance. Int J Mol Sci 2007;8:950–88.
   Web of Science ®Google Scholar
• Masuda M, Suzui M, Weinstein IB. Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res 2001;7:4220–9.
   PubMed Web of Science ®Google Scholar
• Wung BS, Hsu MC, Wu CC, et al. Resveratrol suppresses IL-6-induced ICAM-1 gene expression in endothelial cells: effects on the inhibition of STAT3 phosphorylation. Life Sci 2005;78:389–97.
   PubMed Web of Science ®Google Scholar
• Bharti AC, Donato N, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Immunol 2003;171:3863–71.
   PubMed Web of Science ®Google Scholar
• Nelson KM, Dahlin JL, Bisson J, et al. The essential medicinal chemistry of curcumin. J Med Chem 2017;60:1620–37.
   PubMed Web of Science ®Google Scholar
• Pandey MK, Sung B, Ahn KS, et al. Butein suppresses constitutive and inducible signal transducer and activator of transcription (STAT) 3 activation and STAT3-regulated gene products through the induction of a protein tyrosine phosphatase SHP-1. Mol Pharmacol 2009;75:525–33.
   PubMed Web of Science ®Google Scholar
• Bell C, Hawthorne S. Ellagic acid, pomegranate and prostate cancer – a mini review. J Pharm Pharmacol 2008;60:139–44.
   PubMed Web of Science ®Google Scholar
• Jung JE, Kim HS, Lee CS, et al. Caffeic acid and its synthetic derivative CADPE suppress tumor angiogenesis by blocking STAT3-mediated VEGF expression in human renal carcinoma cells. Carcinogenesis 2007;28:1780–7.
   PubMed Web of Science ®Google Scholar
• Srinivasan M, Sudheer AR, Menon VP. Ferulic acid: therapeutic potential through its antioxidant property. J Clin Biochem Nutr 2007;40:92–100.
   PubMed Web of Science ®Google Scholar
• Petiwala SM, Johnson JJ. Diterpenes from rosemary (Rosmarinus officinalis): defining their potential for anti-cancer activity. Cancer Lett 2015;367:93–102.
   PubMed Web of Science ®Google Scholar
• Rajendran P, Li F, Shanmugam MK, et al. Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade in vitro and in vivo. Cancer Prev Res (Phila) 2012;5:631–43.
   PubMed Web of Science ®Google Scholar
• Schust J, Sperl B, Hollis A, et al. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem Biol 2006;13:1235–42.
   PubMed Web of Science ®Google Scholar
• Switzer C, Cheng RY, Ridnour LA, et al. Dithiolethiones inhibit NF-κB activity via covalent modification in human estrogen receptor-negative breast cancer. Cancer Res 2012;72:2394–404.
   PubMed Web of Science ®Google Scholar
• Reddy BS, Kawamori T, Lubet R, et al. Chemopreventive effect of S-methylmethane thiosulfonate and sulindac administered together during the promotion/progression stages of colon carcinogenesis. Carcinogenesis 1999;20:1645–8.
   PubMed Web of Science ®Google Scholar
• Chandra-Kuntal K, Singh SV. Diallyl trisulfide inhibits activation of signal transducer and activator of transcription 3 in prostate cancer cells in culture and in vivo. Cancer Prev Res 2010;3:1473–83.
   PubMed Web of Science ®Google Scholar
• Juge N, Mithen RF, Traka M. Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol Life Sci 2007;64:1105–27.
   PubMed Web of Science ®Google Scholar
• Switzer CH, Ridnour LA, Cheng RYS, et al. Dithiolethione compounds inhibit Akt signaling in human breast and lung cancer cells by increasing PP2A activity. Oncogene 2009;28:3837–46.
   PubMed Web of Science ®Google Scholar
• Isenberg JS, Jia Y, Field L, et al. Modulation of angiogenesis by dithiolethione-modified NSAIDs and valproic acid. Br J Pharmacol 2007;151:63–72.
   PubMed Web of Science ®Google Scholar
• Moody TW, Switzer C, Santana-Flores W, et al. Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells. Lung Cancer 2010;68:154–60.
   PubMed Web of Science ®Google Scholar
• Wedel SA, Sparatore A, Del Soldato P, et al. New histone deacetylase inhibitors as potential therapeutic tools for advanced prostate carcinoma. J Cell Mol Med 2008;12:2457–66.
   PubMed Web of Science ®Google Scholar
• Tesei A, Brigliadori G, Carloni S, et al. Organosulfur derivatives of the HDAC inhibitor valproic acid sensitize human lung cancer cell lines to apoptosis and to cisplatin cytotoxicity. J Cell Physiol 2012;227:3389–96.
   PubMed Web of Science ®Google Scholar
• Gabriele E, Ricci C, Meneghetti F, et al. Methanethiosulfonate derivatives as ligands of the STAT3-SH2 domain. J Enz Inhib Med Chem 2017;32:337–44.
   PubMed Web of Science ®Google Scholar
• Gabriele E, Porta F, Facchetti G, et al. Synthesis of new dithiolethione and methanethiosulfonate systems endowed with pharmaceutical interest. Arkivoc 2017;II:235–50.
   Google Scholar
• Gilmore TD, Herscovitch M. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 2006;25:6680–4.
   PubMed Web of Science ®Google Scholar
• Natarajan K, Singh S, Burke TR Jr, et al. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. PNAS 1996;93:9090–5.
   PubMed Web of Science ®Google Scholar
• Lin CL, Chen RF, Chen JY, et al. Protective effect of caffeic acid on paclitaxel induced anti-proliferation and apoptosis of lung cancer cells involves NF-κB pathway. Int J Mol Sci 2012;13:6236–45.
   PubMed Web of Science ®Google Scholar
• Chiang EP, Tsai SY, Kuo YH, et al. Caffeic acid derivatives inhibit the growth of colon cancer: involvement of the PI3-K/Akt and AMPK signaling pathways. PLoS One 2014;9:e99631.
   PubMed Web of Science ®Google Scholar
• Lai CS, Lee JH, Ho CT, et al. Rosmanol potently inhibits lipopolysaccharide-induced iNOS and COX-2 expression through downregulating MAPK, NF-kappaB, STAT3 and C/EBP signaling pathways. J Agric Food Chem 2009;57:10990–8.
   PubMed Web of Science ®Google Scholar
• Park KW, Kundu J, Chae IG, et al. Carnosol induces apoptosis through generation of ROS and inactivation of STAT3 signaling in human colon cancer HCT-116 cells. Int J Oncol 2014;44:1309–15.
   PubMed Web of Science ®Google Scholar
• Park JE, Park B, Chae IG, et al. Carnosic acid induces apoptosis through inactivation of Src/STAT3 signaling pathway in human renal carcinoma Caki cells. Oncol Rep 2016;35:2723–32.
   PubMed Web of Science ®Google Scholar
• Wenkert E, Fuchs A, McChesney JD. Chemical artifacts from the family Labiatae. J Org Chem 1965;30:2931–4.
   Web of Science ®Google Scholar
• Boido A, Sparatore F, Biniecka M. N-substituted derivatives of rosmaricine. Preliminary note. Studi Sassaresi 1975;53:383–93; Chem Abstr 1978;88:69046.
   Google Scholar
• Boido A, Savelli F, Sparatore F. Rosmaricine derivatives as potential antitumoral agents. Farmaco 1994;49:111–14.
   PubMedGoogle Scholar
• Uehara Y, Mochizuki M, Matsuno K, et al. Novel high-throughput screening system for identifying STAT3-SH2 antagonists. Biochem Biophys Res Commun 2009;380:627–31.
   PubMed Web of Science ®Google Scholar
• Ferri N, Cazzaniga S, Mazzarella L, et al. Cytotoxic effect of (1-methyl-1H-imidazol-2-yl)-methanamine and its derivatives in Pt(II) complexes on human carcinoma cell lines: a comparative study with cisplatin. Bioorg Med Chem 2013;21:2379–86.
   PubMed Web of Science ®Google Scholar
• Fan LC, Teng HW, Shiau CW, et al. Pharmacological targeting SHP-1-STAT3 signaling is a promising therapeutic approach for the treatment of colorectal cancer. Neoplasia 2015;17:687–96.
   PubMed Web of Science ®Google Scholar
• Ferri N, Garton KJ, Raines EW. An NF-kappaB-dependent transcriptional program is required for collagen remodeling by human smooth muscle cells. J Biol Chem 2003;278:19757–64.
   PubMed Web of Science ®Google Scholar
• Ruscica M, Ricci C, Macchi C, et al. Suppressor of cytokine signaling-3 (SOCS-3) induces proprotein convertase subtilisin kexin type 9 (PCSK9) expression in hepatic HepG2 cell line. J Biol Chem 2016;291:3508–19.
   PubMed Web of Science ®Google Scholar
• Foong LY, You S, Jaikaran DC, et al. Development of a novel thiol reagent for probing ion channel structure: studies in a model system. Biochemistry 1997;36:1343–8.
   PubMed Web of Science ®Google Scholar
• Bruice TW, Kenyon GL. Novel alkyl alkanethiolsulfonate sulfhydryl reagents. Modification of derivatives of L-cysteine. J Protein Chem 1982;1:47–58.
   Google Scholar
• Bottcher B, Bauer F, Trithiones V. Some new trithiones. Chem Ber 1951;84:458–63.
   Google Scholar
• Sparatore A, Del Soldato P, Santus G. New anticancer compounds. Patent WO 2009065926, 2009.
   Google Scholar
• Lee M, Tazzari V, Giustarini D, et al. Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: potential for treating Parkinson disease. J Biol Chem 2010;285:17318–28.
   PubMed Web of Science ®Google Scholar
• Liu HR, Liu Y, Li YI, et al. Synthesis and biological activity of nitric oxide-releasing derivatives of ferulic acid as potential agents for the treatment of chronic kidney diseases. Med Chem 2013;9:875–80.
   PubMed Web of Science ®Google Scholar
• Daquino C, Rescifina A, Spatafora C, et al. Biomimetic synthesis of natural and "unnatural" lignans by oxidative coupling of caffeic esters. Eur J Org Chem 2009;36:6289–300.
   Web of Science ®Google Scholar
• Liu YC, Hsieh CW, Wu CC, et al. Chalcone inhibits the activation of NF-kappaB and STAT3 in endothelial cells via endogenous electrophile. Life Sci 2007;80:1420–30.
   PubMed Web of Science ®Google Scholar
• Vermel EM, Kruglyak SA. Anticancer activity of some alkaloids. Vopr Onkol 1962;8:9–17. Chem Abstr 1962;58:1824g.
   Google Scholar
• Yang SC, Chang SS, Chen HY, et al. Identification of potent EGFR inhibitors from TCM Database@Taiwan. PLoS Comput Biol 2011;7:e1002189.
   PubMed Web of Science ®Google Scholar